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Precise control of the neutrophil death program provides a balance between their defense
functions and safe clearance, whereas impaired regulation of neutrophil death is thought to
contribute to a wide range of inflammatory pathologies. Apoptosis is essential for neutrophil
functional shutdown, removal of emigrated neutrophils, and timely resolution of inflamma-
tion. Neutrophils receive survival and pro-apoptosis cues from the inflammatory microenvi-
ronment and integrate these signals through surface receptors and common downstream
mechanisms. Among these receptors are the leukocyte-specific membrane receptors β2
integrins that are best known for regulating adhesion and phagocytosis. Accumulating
evidence indicate that outside-in signaling through the β2 integrin Mac-1 can generate con-
trasting cues in neutrophils, leading to promotion of their survival or apoptosis. Binding
of Mac-1 to its ligands ICAM-1, fibrinogen, or the azurophilic granule enzyme myeloper-
oxidase suppresses apoptosis, whereas Mac-1-mediated phagocytosis of bacteria evokes
apoptotic cell death. Mac-1 signaling is also target for the anti-inflammatory, pro-resolving
mediators, including lipoxin A4, aspirin-triggered lipoxin A4, and resolvin E1. This review
focuses on molecular mechanisms underlying Mac-1 regulation of neutrophil apoptosis
and highlights recent advances how hierarchy of survival and pro-apoptosis signals can be
harnessed to facilitate neutrophil apoptosis and the resolution of inflammation.
Keywords: neutrophils, Mac-1, apoptosis, lipoxins, resolvins, myeloperoxidase, phagocytosis, resolution of inflam-
mation
INTRODUCTION
Neutrophils form the first line of defense against invading
pathogens or tissue injury. They are rapidly recruited to the sites
of infection/injury and play a prominent role in the initiation and
progression of the inflammatory response. Their many defense
mechanisms that destroy invading pathogens are also capable of
inflicting damage to the surrounding tissue (Nathan, 2006). Under
certain conditions, these harmful consequences became dominant
and prolong inflammation. Once the pathogens are cleared, neu-
trophils are thought to undergo constitutive apoptosis (Savill et al.,
2002). This process renders neutrophils unresponsive to extracel-
lular stimuli, allows their recognition and removal by macrophages
(Savill et al., 2002; Gilroy et al., 2004; Nathan and Ding, 2010)
and limits their potentially harmful actions. Neutrophil accu-
mulation in inflamed tissues is a balance of their recruitment
and removal. Conversely, effective resolution of inflammation
requires cessation of neutrophil recruitment as well as timely
removal of emigrated neutrophils from the site of inflammation.
Apoptosis, which ensures that neutrophils are securely marked
for disposal, emerged as a control point in resolving inflamma-
tion (Filep and El Kebir, 2009; Fox et al., 2010; Perretti, 2012).
Pro-survival and pro-apoptosis signals from the inflammatory
milieu can, however, influence the execution of the constitutive
death program, thereby profoundly affecting the fate of neu-
trophils and the outcome of the inflammatory response (reviewed
in Filep and El Kebir, 2010; Fox et al., 2010; Geering and Simon,
2011).
β2 integrins are leukocyte-specific adhesion molecules that gov-
ern neutrophil adhesion and transmigration across the activated
endothelium and phagocytosis of pathogens (Ross, 2000; Ley et al.,
2007). Growing evidence demonstrates that outside-in signaling
through β2 integrins can generate contrasting cues in neutrophils,
leading to promotion of their survival or apoptosis. This review
will focus on the hierarchy of these signaling circuits and the
underlying molecular mechanisms, and will discuss how interfer-
ence with β2 integrin signaling could be harnessed for promoting
neutrophil apoptosis to enhance the resolution of inflammation.
NEUTROPHIL APOPTOSIS: A CONTROL POINT FOR THE
RESOLUTION OF INFLAMMATION
NEUTROPHIL APOPTOSIS DURING HOMEOSTASIS AND
INFLAMMATION
Mature neutrophils are terminally differentiated cells that have the
shortest lifespan among leukocytes in the circulation. Neutrophil
lifespan is generally thought to be in the range of 8–20 h, though
recent data with in vivo labeling suggest a lifespan of 5.4 days under
physiological conditions in humans (Pillay et al., 2010). Aged
neutrophils die by constitutive (or spontaneous) apoptosis. This
mechanism is essential to maintain the balance of cellular home-
ostasis under physiological conditions (Cartwright et al., 1964;
Coxon et al., 1996). Apoptosis renders neutrophils unresponsive to
extracellular stimuli and leads to expression of “eat-me” signals, so
that neutrophils can be recognized and removed by macrophages
in the spleen and bone marrow and Kupffer cells in the liver (Savill
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et al., 1989, 2002). In mice, these three organs contribute equally
to removal of senescent neutrophils (Furze and Rankin, 2008).
During inflammation, extending the lifespan of neutrophils
during transendothelial migration and at the sites of infection
is critical for efficient destruction of pathogens (Watson et al.,
1997; Savill et al., 2002; Nathan, 2006). Once this is accomplished,
neutrophils may undergo necrosis, apoptosis, NETosis (neutrophil
extracellular trap cell death) (Brinkmann et al., 2004; Fuchs et al.,
2007), or autophagy (Remijsen et al., 2011) with the type of death
profoundly affecting the outcome of the inflammatory response.
Apoptotic neutrophil death in situ has multiple pro-resolution
actions. In addition to becoming unresponsive to agonists and
stopping production of inflammatory mediators, apoptotic neu-
trophils can sequester cytokines (Ariel et al., 2006; Ren et al.,
2008) and their phagocytosis by macrophages induces macrophage
polarization from a pro-inflammatory (M1) to a pro-resolution
(M2) phenotype (Fadok et al., 1998). M2 macrophages secrete
mediators, such as IL-10 and TGFβ, which mediate resolution
and tissue repair (Ariel and Serhan, 2012; Sica and Mantovani,
2012). Interestingly, injection of large quantities of apoptotic
neutrophils protected mice against endotoxin shock (Ren et al.,
2008).
In non-resolving inflammation, neutrophils persist at the
inflamed site and are liable to cause tissue destruction (Nathan and
Ding, 2010; Soehnlein, 2012). Neutrophil recruitment may occur
normally or may become excessive, but neutrophils persist as a
result of delayed apoptosis or decreased clearance by macrophages
(Haslett, 1999; Savill et al., 2002). The abnormal host response
creates a persistent inflammatory microenvironment with ongo-
ing release of inflammatory mediators and damage-associated
molecular patterns (Nathan and Ding, 2010; Serhan, 2011).
NEUTROPHIL APOPTOSIS IN HUMAN DISEASE
The tight regulation of neutrophil death is also evident under
pathological conditions, though it is often difficult to decide
whether prolonged survival or apoptosis is most favorable from the
host’s perspective. Consistently, both accelerated and delayed neu-
trophil apoptosis could have severe pathological consequences. For
example, infections with the opportunistic pathogen Pseudomonas
aeruginosa (Allen et al., 2005), influenza virus A (Colamussi et al.,
1999), or HIV (Elbim et al., 2009) as well as autoimmune dis-
eases, such as systemic lupus erythematosus (Courtney et al.,
1999) shorten neutrophil lifespan by accelerating apoptosis, lead-
ing to impaired antimicrobial defenses and increased susceptibility
to recurrent infections. Intracellular pathogens may use apop-
totic neutrophils as a Trojan horse to infect and propagate in
macrophages (Laskay et al., 2008; Rupp et al., 2009). On the
other hand, delayed neutrophil apoptosis appears to be a com-
ponent of the pathophysiology in patients with inflammatory
diseases, including acute respiratory distress syndrome (ARDS)
(Matute-Bello et al., 1997; chronic pulmonary obstructive dis-
ease (COPD) (Brown et al., 2009), viral pneumonia (Lindemans
et al., 2006), sepsis (Ertel et al., 1998), burn (Chitnis et al., 1996),
acute coronary artery disease (Garlichs et al., 2004), rheuma-
toid arthritis (Wong et al., 2009), and cystic fibrosis (McKeon
et al., 2008), and frequently correlates with disease severity and
outcome.
DISTINCT MOLECULAR FEATURES OF NEUTROPHIL APOPTOSIS
A complex network of intracellular death and survival pathways
regulates neutrophil apoptosis and the balance of these circuits
would ultimately determine the fate of neutrophils. Since neu-
trophils undergo apoptosis even in the absence of any extracellular
stimuli, this type of death is called spontaneous or constitutive
programed cell death. However, under most conditions, neu-
trophils receive both pro-survival and pro-apoptosis cues, and
the net effect is likely determined by the balance of these signals.
Neutrophil apoptosis shares many morphological features with
apoptosis in other cell types; however, it involves distinct molecu-
lar mechanisms in executing the cell death program. Predominant
expression of the anti-apoptotic protein myeloid cell leukemia-1
(Mcl-1), restricted function of mitochondria to apoptosis, ROS
production, release of proteases from azurophilic granules, and
unusual roles for nuclear proteins are hallmarks of regulation of
apoptosis in neutrophils.
Mcl-1 REGULATION OF NEUTROPHIL SURVIVAL AND APOPTOSIS
Spontaneous neutrophil apoptosis rely upon the balance of
pro- and anti-apoptotic members of the Bcl-2 family. Mature
human neutrophils constitutively express the pro-apoptotic Bcl-
2-associated X protein (Bax), Bcl-2-associated death promoter
(Bad), Bcl-2 homologous antagonist/killer (Bak), Bcl-2 homology-
3 (BH-3)-interacting domain death agonist (Bid), Bcl-2 interact-
ing protein (Bim), and Bcl-2 interacting killer (Bik) as well as
the anti-apoptotic Bcl-2 homolog Mcl-1, and to a much lesser
extent A1 and Bcl-XL, but not Bcl-2 (Akgul et al., 2001; Mould-
ing et al., 2001). The pro-apoptotic Bcl-2 homologs have relatively
long half-lives and their cellular levels change very little during
exposure of neutrophils to agents that either accelerate or delay
apoptosis. Genetic deletion of bim or bax/bak results in increased
neutrophil numbers in mice (Lindsten et al., 2000). Mcl-1 con-
tains a PEST domain [rich in proline (P), glutamic acid (E), serine
(S), and threonine (T)], which facilitates its proteasomal degra-
dation, resulting in a very short half-life (Edwards et al., 2004).
Mcl-1 levels closely correlate with neutrophil survival kinetics
(Moulding et al., 1989; Hamasaki et al., 1998; Leuenroth et al.,
2000; Kato et al., 2006; Dzhagalov et al., 2007). Survival of myeloid
cells decreases following treatment with antisense oligonucleotides
against Mcl-1 (Moulding et al., 2000). Myeloid lineage-specific
knockout of mcl-1 reduces neutrophil numbers by accelerating
apoptosis (Dzhagalov et al., 2007; Steimer et al., 2009). Recent data
indicate that Mcl-1 levels drop in advance of apoptosis, even in the
presence of caspase inhibitors (Wardle et al., 2011), indicating that
Mcl-1 functions as a regulator and a downstream target of caspase
activation. On the other hand, unchanged or even increased Mcl-
1 expression has been detected in neutrophils of patients with
Crohn’s disease (Catarzi et al., 2008) or severe sepsis (Fotouhi-
Ardakani et al., 2010). Mcl-1 promotion of neutrophil survival is
thought to involve heterodimerization with and neutralization of
Bim or Bak in the mitochondrial outer membrane (Reed, 2006;
Brenner and Mak, 2009), resulting in maintenance of the mito-
chondrial transmembrane potential (∆Ψm) and prevention of
release of pro-apoptotic proteins.
Mature neutrophils contain a low number of mitochondria
that may have a role restricted to apoptosis (Maianski et al.,
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2004). Thus, mitochondrial respiration in mature neutrophils is
low and mitochondria generate only small amounts of ATP by
oxidative phosphorylation (Maianski et al., 2004). The mitochon-
drial poison cyanide does not affect neutrophil function. Nev-
ertheless, neutrophil mitochondria maintain a transmembrane
potential, forms a complex network that plays a role in chemo-
taxis, phagocytosis, and triggering apoptosis (Fossati et al., 2003).
Mitochondria contains pro-apoptotic proteins cytochrome c, sec-
ond mitochondria-derived activator of caspases (Smac)/DIABLO
(direct IAP-binding protein with low pl), apoptosis-inducing fac-
tor (AIF), and endonuclease G (Saelens et al., 2004). Loss of ∆Ψm
evokes release of these proteins. Cytochrome c and Smac appear
to be required for optimal caspase-3 activation (Altznauer et al.,
2004). Loss of∆Ψm precedes development of apoptotic morphol-
ogy in neutrophils undergoing constitutive (Maianski et al., 2004)
and induced apoptosis.
ROLE OF REACTIVE OXYGEN SPECIES AND REDOX BALANCE
Neutrophils generate high amounts of ROS by NADPH oxidase
in response to soluble stimuli as well as following phagocytosis of
bacteria in order to destroy invading pathogens (Nauseef, 2007).
High amounts ROS can inflict damage to the surrounding cell
and evoke necrosis. ROS also function as intracellular signaling
molecules. The intrinsic or mitochondrial pathway of apoptosis
is likely initiated through ROS generation (Kasahara et al., 1997;
Maianski et al., 2004; Xu et al., 2010), though the source(s) of
ROS in aging non-activated neutrophils is still unknown. Lig-
ation of the cell surface death receptors, TNF, Fas, or TRAIL
(TNF-related apoptosis-inducing ligand) receptors triggers the
formation of the death-inducing signaling complex (DISC), which
through downstream adaptor proteins, such as Fas-associated
death domain (FADD) leads to activation of NADPH oxidase
and cleavage of caspase-8 (Green, 2000). Likewise, phagocytosis
of opsonized microorganisms through complement and/or Fcγ
receptors evokes ROS-mediated activation of caspase-8 and sub-
sequently caspase-3, leading to neutrophil apoptosis (Watson et al.,
1996; Perskvist et al., 2002; DeLeo, 2004). Consistent with these
findings, patients with chronic granulomatous diseases that lacks
functional NADPH oxidase exhibit increased neutrophil viability
(Fadeel et al., 1998) and reduced neutrophil apoptosis following
ingestion of bacteria (Coxon et al., 1996). The effects of ROS are
balanced by neutrophil antioxidant defenses, including catalase,
superoxide dismutase, and glutathione. These proteins become
depleted during ex vivo culture of neutrophils parallel with devel-
opment of apoptotic morphology (Watson, 2002; Melley et al.,
2005). Loss of GSH by chloramines or GSH depletion during acti-
vation of the respiratory burst predisposes to apoptosis (Melley
et al., 2005).
REGULATION OF APOPTOSIS BY GRANULAR AND NUCLEAR PROTEINS
Certain granular and nuclear proteins have also been implicated
in the modulation of the cell death program. For example, cathep-
sin D is released from the azurophilic granules during apopto-
sis and may contribute to activation of caspase-3 through pro-
cessing of caspase-8 and Bid (Conus et al., 2008). Consistently,
pharmacological or genetic inhibition of cathepsin D results in
delayed neutrophil apoptosis. Mature neutrophils constitutively
express the cyclin-dependent kinases CDK1, CDK2, and CDK5
(Rosales et al., 2004; Rossi et al., 2006). Culture of neutrophils
with R-roscovitine, a non-selective inhibitor of cyclin-dependent
kinases enhances apoptosis likely through down-regulation of
Mcl-1 expression (Rossi et al., 2006; Leitch et al., 2010). Unlike
in other cell types, proliferating cell nuclear antigen (PCNA) is
expressed in the cytoplasm of mature neutrophils and is bound
to pro-caspases, resulting in suppression of neutrophil apopto-
sis (Witko-Sarsat et al., 2010). Conversely, decreased cytoplasmic
PCNA expression resulted in augmented neutrophil apoptosis. In
contrast, during constitutive apoptosis, another nuclear protein
myeloid nuclear differentiation antigen (MNDA) is cleaved by
caspases and accumulates in the cytoplasm, where it promotes
proteasomal degradation of Mcl-1 and subsequently collapse of
mitochondrial transmembrane potential (Fotouhi-Ardakani et al.,
2010). Bacterial constituents and platelet-activating factor pre-
vent cytoplasmic MNDA accumulation parallel with preservation
of Mcl-1 and suppression of apoptosis (Fotouhi-Ardakani et al.,
2010).
SUPPRESSION OF APOPTOSIS: INTRACELLULAR SURVIVAL PATHWAYS
Although apoptosis is a default fate of neutrophils, in the inflam-
matory microenvironment, neutrophils are likely exposed to
various pro-survival signals, including granulocyte macrophage
colony stimulating factor (GM-CSF) (Colotta et al., 1992; Lee et al.,
1993), leukotriene B4 (Lee et al., 1999), C5a (Lee et al., 1993), the
acute-phase reactants C-reactive protein (Khreiss et al., 2002), and
serum amyloid A (El Kebir et al., 2007; Christenson et al., 2008) as
well as bacterial constituents LPS (Colotta et al., 1992; Lee et al.,
1993) and bacterial DNA (József et al., 2004). Multiple kinase
pathways are involved in determining the fate of neutrophils. For
example, GM-CSF activates the Jak2/STAT and phosphoinositide-
3-kinase (PI3K)/Akt pathways, leading to preservation of Mcl-1
expression and retardation of apoptosis (Klein et al., 2000; Epling-
Burnette et al., 2001). PI3K generates PtdIns(3,4,5)P3, which also
influences NF-κB and cAMP-response-element-binding protein
(CREB) and thus may generate additional pro-survival signals
(Ward et al., 2004). Many inflammatory mediators also activate
the MAPK/ERK pathway that, in turn, inhibits the intrinsic path-
way of apoptosis (Filep and El Kebir, 2010; Geering and Simon,
2011). ERK 1/2 and Akt phosphorylate Bad and Bax, leading
to dissociation of phosphorylated Bad and Bax from the anti-
apoptotic protein Mcl-1 (Akgul et al., 2001; El Kebir et al., 2007).
Concomitant activation of Akt and ERK appears to be required
for suppression of neutrophil apoptosis, and transient activation
of Akt without ERK activation may not be sufficient to delay
the death program. Contradictory results have been reported for
p38 MAPK; its action on neutrophil survival may be stimulus
and/or context-specific (reviewed in Filep and El Kebir, 2010). For
example, pro-survival function of p38 MAPK may include phos-
phorylation, and therefore inactivation of caspase-3 and caspase-8
(Alvarado-Kristensson et al., 2003). In other studies, constitutive
or TNF-induced neutrophil apoptosis was found to be associated
with phosphorylation of p38 MAPK (Khreiss et al., 2002; El Kebir
et al., 2007). Activation of p38 MAPK by sodium salicylate is asso-
ciated with reduced Mcl-1 expression and acceleration of apoptotic
cell death (Derouet et al., 2006).
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NEUTROPHIL β2 INTEGRINS MODULATE LIFE AND DEATH
DECISIONS
β2 INTEGRIN ACTIVATION AND FUNCTION
The β2 integrin (αβ) family consists of LFA-1 (leukocyte function-
associated antigen 1, CD11a/CD18), Mac-1 (CD11b/CD18, αMβ2
integrin, ITAM antigen), p150,95 (CD11c/CD18, αXβ2 integrin,
ITAX antigen), and αdβ2 (CD11d/CD18, ITAD antigen). The
β2 integrins are in an inactive (low affinity) conformation on
circulating leukocytes. Leukocyte agonists trigger inside-out sig-
naling that through activation of Rap1 (reviewed in Evans et al.,
2009) induces conformational changes that reflect the intermedi-
ate and high affinity states of Mac-1 (Xiong et al., 2001; Luo et al.,
2007). Ligand occupancy, but not integrin clustering promotes
switchblade-like extension of the Mac-1 extracellular domain and
separation of the αM and β2 subunit cytoplasmic tails, structural
hallmarks of integrin activation (Lefort et al., 2009). These lead
to enhanced affinity for binding their ligand and/or regulation
of avidity. Integrin activation is a complex and tightly regulated
process which involves displacement of inhibitory proteins from
the integrin cytoplasmic tail followed by targeting integrin activa-
tors or activator complexes, such as talin, kindlins, integrin-linked
kinase, and migfilin (Kim et al., 2011). β2 integrins contribute
to diverse neutrophil functions critical for innate immunity. Acti-
vated β2 integrins mediate leukocyte adhesion and transmigration
across the endothelium through interactions with ICAM-1 on the
activated endothelial cells (Ley et al., 2007; Abram and Lowell,
2009). Mac-1 also mediates other neutrophil adhesion-dependent
functions, including binding to fibrinogen (Pluskota et al., 2004),
immune complexes, and platelets (through Gp1b) (Mayadas and
Cullere, 2005) and suppression of T cell proliferation (Pillay et al.,
2012). Mac-1 and CD11c/CD18 are specific receptors for com-
plement iC3b and mediate efficient phagocytosis of complement-
opsonized targets, though they can also recognize many pathogens
directly (Ross, 2000). Mac-1 functionally cooperates with other
surface receptors, including TNF receptor, FcγRs, Toll-like recep-
tor 2 (TLR2), and CD14 (Ehlers, 2000; Ross, 2000; Kobayashi et al.,
2002; Salamone et al., 2004).
Mac-1-MEDIATED PRO-SURVIVAL SIGNALING
Outside-in signaling through Mac-1 could generate contrasting
cues for neutrophils in a context-dependent fashion (Figure 1).
Transendothelial migration of neutrophils (Watson et al., 1997;
Yan et al., 2004) or neutrophil adherence to Mac-1 ligands, ICAM-,
fibrinogen, and plasminogen, prolongs their lifespan by delay-
ing apoptosis (Table 1). Binding of ICAM-1 to Mac-1 induces
activation of the PI3k/Akt survival pathway (Whitlock et al.,
2000). Fibrinogen-mediated suppression of neutrophil apopto-
sis also depends on Akt in addition to activation of NF-κB and the
MAPK/ERK pathway (Rubel et al., 2003). Crosslinking activated
Mac-1 with anti-Mac-1 antibody (Fab fragments) or clustering
inactive Mac-1 in neutrophils in suspension signals survival cues
through activation of Akt and ERK (Whitlock et al., 2000). Sol-
uble fibrinogen activates neutrophils, as assessed by upregulation
of Mac-1 expression and elevation of intracellular calcium con-
centration (Rubel et al., 2003; Pluskota et al., 2008), indicating
that Mac-1-mediated adhesion per se is not a prerequisite for gen-
eration of survival signals. Engagement of both Mac-1 subunits
with these ligands is a prerequisite for induction of pro-survival
signals (Pluskota et al., 2008). Consistently, angiostatin, derived
from plasminogen and neutrophil inhibitory factor (NIF), which
interact primarily with the αM subunit do not trigger phospho-
rylation of ERK 1/2 and Akt and do not rescue neutrophils from
constitutive apoptosis (Pluskota et al., 2008).
Heparin also binds to Mac-1. Immobilized heparin can mediate
leukocyte adhesion (Diamond et al., 1995), whereas unfraction-
ated soluble heparin was reported to inhibit binding of fibrinogen
FIGURE 1 | Contrasting outside-in signals through Mac-1 modulates
survival and death decision in neutrophils. Aging neutrophils undergo
constitutive apoptosis triggered by collapse of mitochondrial function.
Engagement of Mac-1 with its ligands ICAM-1, fibrinogen, or MPO delays
apoptosis by generating survival cues through activation of the PI3K/Akt and
MEK/ERK pathways. Additional stimulation of death receptors with TNF or
FasL evokes release of ROS, which through activation of lyn and SHIP leads
to inhibition of Akt. Mac-1-mediated phagocytosis of opsonized bacteria
evokes ROS production by NADPH oxidase, leading to ROS-mediated
activation of caspase-8 and inhibition of ERK, and acceleration of the cell
death program. Apoptotic neutrophils are recognized and phagocytosed by
macrophages (efferocytosis), thus contributing to inflammatory resolution.
Extended neutrophil longevity contributes to aggravation and prolongation of
the inflammatory response.
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Table 1 | Selective regulation of neutrophil apoptosis by different ligands of Mac-1.
Ligand Action(s) Effect on apoptosis Reference
ICAM-1 Mediates PMN adhesion and transmigration Suppresses apoptosis Watson et al. (1997)
Whitlock et al. (2000)
Yan et al. (2004)
Fibrinogen Precursor of fibrin initiates coagulation Suppresses apoptosis Rubel et al. (2001)
Rubel et al. (2003)
Pluskota et al. (2004, 2008)
Plasminogen Precursor of plasmin initiates fibrinolysis Suppresses apoptosis Pluskota et al. (2008)
Angiostatin Inhibits angiogenesis No effect Pluskota et al. (2008)
Myeloperoxidase Bacterial killing upregulates Mac-1 expression induces
MPO release
Suppresses apoptosis El Kebir et al. (2008)
Lau et al. (2005)
Heparin Anticoagulant
Immobilized mediates leukocyte adhesion Induces apoptosis Diamond et al. (1995)
Soluble inhibits binding of fibrinogen Not known Manaster et al. (1996)
Soluble, low molecular weight No effect Peters et al. (1999)
Erduran et al. (1999)
Brown et al. (2012)
Opsonized bacteria Phagocytosis destruction of bacteria Induces apoptosis Coxon et al. (1996)
Watson et al. (1999)
Arroyo et al. (2002)
Zhang et al. (2003)
Perskvist et al. (2002)
DeLeo (2004)
MPO, myeloperoxidase; PMN, polymorphonuclear granulocytes.
and complement iC3b to Mac-1 (Peters et al., 1999). Inconsistent
reports have been published on the effect of heparin on neutrophil
lifespan. Unfractionated heparin was reported to induce apoptosis
(Manaster et al., 1996), whereas low molecular weight heparin did
not affect neutrophil apoptosis (Erduran et al., 1999; Brown et al.,
2012).
In the presence of TNF or anti-Fas activating antibody,
crosslinking Mac-1 with activating antibodies promotes neu-
trophil apoptosis (Whitlock et al., 2000). Activation of TNF
receptor or Fas results in NADPH oxidase-mediated ROS gen-
eration and extracellular ROS release, leading to activation of
SHIP [Src-homology 2(SH2)-containing inositol 5-phosphatase],
which hydrolyzes PI3K products through the Src kinase Lyn (Gar-
dai et al., 2002). This would lead to decreased Akt phosphorylation.
Although Lyn was reported to exert anti-apoptotic actions in gran-
ulocytes (Daigle et al., 2002), exogenous H2O2 can activate Lyn
independently of adhesion (Yan and Berton, 1996). ROS, most
likely H2O2 that was released extracellularly might diffuse back
into cells to suppress the PI3K/Akt survival signal (Zhu et al., 2006;
Xu et al., 2010). Whether ROS affect signaling pathways leading to
activation of PI3K or through activation of PTEN (phosphatase
and tensin homolog) is still uncertain. PTEN converts phos-
phatidylinositol 3,4,5-triphosphate to phosphatidylinositol-4,5-
diphosphate, thus preventing activation of Akt. PTEN-null neu-
trophils live longer than wildtype neutrophils (Zhu et al., 2006).
In contrast, crosslinking Mac-1 with clustering non-activating
antibodies or recombinant ICAM-1 results in partial attenuation
of Fas-triggered apoptosis through sustained ERK activation and
elevation in reduced glutathione (GSH) levels (Watson et al., 1997;
Whitlock et al., 2000). The biological significance of differences in
neutrophil responses to Mac-1 activating versus clustering anti-
bodies remains to be investigated. TNF promotion of neutrophil
apoptosis evoked by immune complexes or zymosan partially
depends on Mac-1 (Salamone et al., 2004), suggesting functional
cooperation of Mac-1 with Fcγ or zymosan receptors (Ehlers,
2000; Ross, 2000).
While most studies investigated Mac-1 signaling, ligation of
LFA-1 may also generates contrasting cues for neutrophils. LFA-
1-deficient mice exhibit neutrophilia and enhanced resistance
to L. monocytogenes without changes in spontaneous apoptosis
(Miyamoto et al., 2003). Similar to Mac-1, ligation of LFA-1 during
transendothelial migration suppresses caspase-3 activation and
thus delays apoptosis in neutrophils (Yan et al., 2004). In contrast,
activation of ICAM-3 with a monoclonal antibody that recognizes
an ICAM-3 epitope that binds its ligand LFA-1 was found to induce
apoptosis (Kessel et al., 2006).
Mac-1-MEDIATED ACCELERATION OF APOPTOSIS
Phagocytosis of opsonized bacteria or other targets accelerates
apoptosis in neutrophils, also referred to as phagocytosis-induced
cell death or PICD (Coxon et al., 1996;Watson et al., 1999; Perskvist
et al., 2002; DeLeo, 2004). Mac-1-mediated phagocytosis evokes
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NADPH-dependent ROS generation within the phagolysosomes
(Karlsson and Dahlgren, 2002) and is thought to contribute to
killing bacteria (Nauseef, 2007) as well as to triggering PICD (Wat-
son et al., 1996; Zhang et al., 2003). Consistently, patients with
chronic granulomatous disease, who have low level of NADPH
oxidase due to genetic mutations in gp91phox or other phox genes,
suffer from recurrent infections (Heyworth et al., 2003) and their
neutrophils do not undergo PICD (Coxon et al., 1996).
Mac-1-mediated phagocytosis evokes generation of NADPH
oxidase-derived ROS, which, in turn, leads to activation of caspase-
8 and subsequently caspase-3 (Arroyo et al., 2002; Zhang et al.,
2003). ROS, most likely hydroxyl radicals and H2O2 (Watson et al.,
1996; Perskvist et al., 2002) released within phagosomes might leak
and trigger PICD. Superoxide released extracellularly is rapidly dis-
mutated to H2O2, which might diffuse back to the cell to affect the
redox status and signaling pathways. As caspase-8 activation is a
signature of death receptor-mediated apoptosis, Mac-1 has been
suggested to function as a death receptor, even though it does not
contain a recognized death effector domain (Mayadas and Cullere,
2005). It should be noted that many stimuli that generate varying
amounts of NADPH oxidase-derived ROS do not trigger neu-
trophil death. For example, GM-CSF enhances ROS production
upon yeast phagocytosis, but inhibits PICD (Zhang et al., 2003).
Thus, the amount, nature, and intra- or extracellular release of
NADPH oxidase-derived ROS would likely determine their pro-
apoptosis potential. PICD occurs despite phagocytosis-induced
activation of the MAPK/ERK pathway (Zhang et al., 2003), indi-
cating that ROS triggered pro-apoptosis signals effectively override
survival cues. In contrast, GM-CSF evokes a more robust ERK
phosphorylation in phagocytosing neutrophils, leading to gener-
ation of strong competing survival signals that shift the life-death
balance toward survival (Zhang et al., 2003).
MYELOPEROXIDASE: A LIGAND FOR Mac-1 AND SURVIVAL SIGNAL FOR
NEUTROPHILS
An unexpected ligand for Mac-1 is myeloperoxidase (MPO),
the most abundant granule enzyme in neutrophils (Schultz and
Kaminker, 1962; Borregaard and Cowland, 1997). MPO, MPO-
generated reactive oxidants, hypochlorous acid (HOCl) in par-
ticular and diffusible radical species have been implicated in
the elimination of microbes (Klebanoff, 2005; Nauseef, 2007;
Davies et al., 2008) as well as in inflicting tissue damage (Kle-
banoff, 2005; Winterbourn, 2008; Arnhold and Flemming, 2010).
Non-activated neutrophils bind to MPO-coated surfaces (Johans-
son et al., 1997) or “free” circulating MPO through Mac-1 (Lau
et al., 2005). Increased MPO association with neutrophil mem-
brane was detected in blood from patients with inflammatory
diseases, including sepsis, ischemia-reperfusion, or acute coro-
nary syndromes compared with healthy controls (Lau et al., 2005).
Membrane-bound MPO correlates with plasma MPO levels, indi-
cating up-regulation of MPO export toward the plasma membrane
as well as a potential for binding of free MPO to the neutrophil
surface.
MPO binding to Mac-1 on human neutrophils leads to
increased tyrosine phosphorylation (Lau et al., 2005), phospho-
rylation of p38 MAPK (Lau et al., 2005; El Kebir et al., 2008), ERK
1/2 and PI3K (El Kebir et al., 2008), and activation of NF-κB (Lau
et al., 2005). Activation of p38 MAPK induces phosphorylation of
p47phox, the cytoplasmic regulatory subunit of NADPH oxidase
(Babior, 2004), leading to superoxide formation (Lau et al., 2005),
and regulates NF-κB-mediated transcription of genes involved in
the acute inflammatory response (Park et al., 2003). Intriguingly,
MPO also upregulates surface expression of Mac-1 on neutrophils
(Lau et al., 2005; El Kebir et al., 2009) through yet unidentified
molecular mechanisms. MPO binding to Mac-1 induces release
of elastase and MPO from the azurophilic granules (Lau et al.,
2005). These findings are consistent with the central role of Mac-
1-mediated outside-in signaling in degranulation (Harris et al.,
2000), and imply an autocrine/paracrine mechanism for amplify-
ing neutrophil responses to MPO (Figure 2) (El Kebir et al., 2008,
2009).
MPO, independent of its catalytic activity, rescues neutrophils
from constitutive apoptosis through simultaneous activation of
ERK 1/2 and Akt, Mcl-1 accumulation and suppression of the
mitochondrial pathway of apoptosis (El Kebir et al., 2008). Consis-
tently, MPO prevents cytochrome c release from the mitochondria
and subsequent activation of caspase-3 (El Kebir et al., 2008).
MPO-induced phosphorylation of p38 MAPK does not gener-
ate a survival signal, for pharmacological blockade of p38 MAPK
retards neutrophil apoptosis both in the absence and presence of
MPO (El Kebir et al., 2008). In contrast to these findings, MPO
was found to mediate apoptosis in HL60 leukemia cells (Wagner
et al., 2000; Kanayama and Miyamoto, 2007). While the involve-
ment of Mac-1 in the pro-apoptosis action of MPO has not been
elucidated, Mac-1 may play opposing roles in determining the
fate of primary and leukemia cells likely by shifting the balance of
pro-survival and pro-apoptosis cues. It is intriguing that MPO can
prolong the lifespan of neutrophils, the predominant source of this
enzyme and that function-blocking monoclonal anti-Mac-1 anti-
bodies can almost completely prevent MPO-induced activation
(Lau et al., 2005; El Kebir et al., 2008) and suppression of con-
stitutive apoptosis of human neutrophils in vitro (El Kebir et al.,
2008).
MYELOPEROXIDASE PROLONGS NEUTROPHIL LIFESPAN AND DELAYS
RESOLUTION OF INFLAMMATION
Acute elevation of plasma MPO levels to levels similar to those
detected in patients with inflammatory vascular diseases (Brennan
et al., 2001; Baldus et al., 2003) results in prolongation of the lifes-
pan of rat neutrophils through suppression of apoptosis as assayed
ex vivo (El Kebir et al., 2008). MPO also suppresses neutrophil
apoptosis in a mouse model of carrageenan-induced lung injury
and delays spontaneous self-resolution of pulmonary inflamma-
tion (El Kebir et al., 2008). Thus, combined administration of
carrageenan and MPO evokes persisting lung injury/inflammation
with few airway neutrophil exhibiting signs of apoptosis even
5 days post-injection, when pulmonary inflammation is almost
completely resolved in the lungs of carrageenan-injected mice. The
effects of MPO closely resemble those of zVAD-fmk, a pan-caspase
inhibitor, which aggravates and prolongs carrageenan-elicited
acute pleurisy (Rossi et al., 2006) and lung inflammation (El
Kebir et al., 2008). MPO-deficient mice exhibit lower pulmonary
bacterial colonization, reduced lung injury, and greater survival
following intraperitoneal injection of Escherichia coli compared
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FIGURE 2 | Myeloperoxidase (MPO)-Mac-1 self-amplifying circuit
promotes neutrophils survival and inflammation. MPO binding to Mac-1
results in p38 MAPK-mediated NADPH oxidase, and PI3K/Akt and
MEK/ERK-mediated preservation of the anti-apoptotic protein Mcl-1, leading
to suppression of apoptosis. MPO also triggers MPO release from the
azurophilic granules, and upregulates Mac-1 expression, thereby forming an
autocrine/paracrine self-amplifying circuit. MPO catalyzed formation of HOCl,
activation of NF-κB-regulated transcription of pro-inflammatory genes,
recruitment of neutrophils, and prolongation of neutrophil longevity contribute
to tissue damage and inflammation.
with wild type mice (Brovkovych et al., 2008). MPO deficiency
also reduces ischemia/reperfusion-induced renal dysfunction and
neutrophil accumulation in mice, but fails to abrogate apopto-
sis during early phases of reperfusion (Matthijsen et al., 2007).
Intriguingly, MPO-deficient mice exhibit elevated baseline pul-
monary inducible NO synthase expression and NO production
that may partially compensate for the lack of HOCl-mediated
bacterial killing (Brovkovych et al., 2008). The mechanism(s)
responsible for upregulation of inducible NO synthase as well as
the impact of enhanced NO production on the resolution of lung
inflammation remains to be explored. Absence of MPO-derived
oxidant production during E. coli septicemia in MPO-null mice is
consistent with reduced lung injury and mortality. Further studies
are required to investigate whether MPO deficiency could affect
the lifespan of emigrated or circulating neutrophils, and whether
changes in neutrophil longevity could contribute to protection
against lung injury in this model of sepsis.
TARGETING Mac-1 SIGNALING FOR THERAPEUTIC
INDUCTION OF NEUTROPHIL APOPTOSIS
Accumulating experimental and clinical data suggest a causal
relationship between neutrophil apoptosis and outcome of
inflammation. Apoptosis of emigrated neutrophils has multiple
pro-resolution actions. It renders neutrophils unresponsive to
agonists and apoptotic neutrophils stop producing and releasing
pro-inflammatory mediators. Apoptotic leukocytes sequester
cytokines (Ariel et al., 2006; Ren et al., 2008) and phagocytosis
of apoptotic cells induces macrophage polarization from a pro-
inflammatory to a pro-resolution phenotype (Fadok et al., 1998;
Ariel and Serhan, 2012; Sica and Mantovani, 2012). Injection of
large number of apoptotic neutrophils protects mice against LPS-
induced shock (Ren et al., 2008). Recent studies identified several
classes of molecules for therapeutic induction of apoptosis in
neutrophils for enhancing the resolution of inflammation.
LIPOXINS INHIBIT MPO SIGNALING THROUGH Mac-1 AND REDIRECTS
NEUTROPHILS TO APOPTOSIS
The pivotal role of MPO in host defense and tissue injury makes
it an attractive target for drug development. Indeed, while a num-
ber of promising compounds have been developed to inhibit the
enzymatic activities of MPO, only limited information is available
on their mechanisms of MPO inhibition and biological activi-
ties (reviewed in Malle et al., 2007). Targeting MPO signaling
through Mac-1 has emerged as an alternative approach to counter
the non-enzymatic activities of MPO.
Lipoxin A4 (LXA4) and aspirin-triggered 15-epi-LXA4 are typ-
ically generated by transcellular biosynthesis at sites of inflamma-
tion (Serhan et al., 2008; Serhan, 2011). In the aspirin-triggered
pathway, acetylation of cyclooxygenase at Ser530 by aspirin (Clària
and Serhan, 1995) or S-nitrosylation at Cys526 by atorvastatin
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(Birnbaum et al., 2006) catalyzes the conversion of arachidonate
to 15R-HETE that can be converted by neutrophils and other
cells to 15-epi-LXA4 and 15-epi-LXB4. LXA4 and 15-epi-LXA4
possess potent anti-inflammatory and pro-resolution actions pre-
dominantly through affecting the function of leukocytes. Lipoxins
stimulate recruitment of monocytes and inhibit neutrophil traf-
ficking and accumulation in inflamed tissues (reviewed in Ser-
han et al., 2007; Serhan et al., 2008). These actions are, in part,
mediated through down-regulation of leukocyte Mac-1 expres-
sion (Fiore and Serhan, 1995; Filep et al., 1999). Accumulation
of PGE2 at inflammatory sites induces a lipid mediator class
switching from a predominantly 5-lipoxygenase activity to a 15-
lipoxygenase activity generating LXA4 parallel with the resolution
of inflammation (Levy et al., 2001) Thus, initiation of an inflam-
matory response would also activate subsequent pro-resolution
mechanisms (Serhan and Savill, 2005).
Lipoxins exert multipronged actions to counter neutrophil
responses to MPO. Down-regulation of Mac-1 expression on neu-
trophils and inhibition of neutrophil adhesion and transendothe-
lial migration are important components of the anti-inflammatory
activities of LXA4 and 15-epi-LXA4 (Serhan et al., 2008). 15-
epi-LXA4 also prevents MPO-induced up-regulation of Mac-1
expression and MPO release, thereby interrupting MPO-mediated
autocrine/paracrine loop for perpetuation of the inflammatory
response (Figure 3) (El Kebir et al., 2009). 15-epi-LXA4 inhi-
bition of NADPH oxidase-derived superoxide generation (Levy
et al., 1999) and subsequent formation of ONOO− (József et al.,
2002) result in reduced NF-κB activation and transcription of
pro-inflammatory cytokines, such as IL-8 (József et al., 2002).
Lipoxins themselves do not appear to interfere with the
apoptotic machinery in neutrophils, whereas they can override
the potent outside-in Mac-1-mediated survival signal and redi-
rect neutrophils to apoptosis in vitro (El Kebir et al., 2009).
15-epi-LXA4 attenuates MPO-evoked ERK and Akt-mediated
phosphorylation of the pro-apoptotic protein Bad and decreases
Mcl-1 expression, critical events in enhancing neutrophil apop-
tosis. Non-phosphorylated Bad associates with Mcl-1 and pre-
vents its anti-apoptotic actions (Reed, 2006). These would aggra-
vate mitochondrial dysfunction, ultimately leading to caspase-
3-mediated cell death (El Kebir et al., 2009; Wardle et al.,
2011).
Treatment of mice with 15-epi-LXA4 at the peak of inflam-
mation enhances resolution of carrageenan plus MPO-induced
and E. coli septicemia-associated acute lung injury and improves
the survival rate (El Kebir et al., 2009). 15-epi-LXA4 reduces pul-
monary neutrophil accumulation with concomitant increases in
the percentage of apoptotic neutrophils in the airways, facili-
tates recruitment of monocytes/macrophages and phagocytosis of
apoptotic neutrophils and other cells (El Kebir et al., 2009), consis-
tent with tissue repair (Godson et al., 2000; Mitchell et al., 2002).
Furthermore, LXA4 released at sites of inflammation protects
macrophages from apoptosis (Prieto et al., 2010). The benefi-
cial actions of 15-epi-LXA4 can be prevented in the presence of
a pan-caspase inhibitor, indicating the importance of neutrophil
apoptosis in inflammatory resolution. Recent results indicate that
aspirin or lovastatin reduction of acid aspiration-induced lung
inflammation is, in part, mediated through stimulation of synthe-
sis of 15-epi-LXA4 (Fukunaga et al., 2005; Planaguma et al., 2010).
The direct effect of lovastatin on neutrophil apoptosis remains,
however, to be investigated. Both aspirin and sodium salicylate
promote neutrophil apoptosis and enhance their phagocytosis
by macrophages in thioglycollate-induced peritonitis (Negrotto
et al., 2006). A recent study reported that serum amyloid A
acting through the formyl-peptide receptor 2/lipoxin receptor
(FPR2/ALX) can overwhelm anti-inflammatory signaling by LXA4
to mediate exacerbation of glucocorticoid refractory lung inflam-
mation in patients with chronic obstructive pulmonary disease
(Bozinovski et al., 2012).
FIGURE 3 | Multipronged actions of lipoxins to inhibit the
myeloperoxidase (MPO)-Mac-1 circuit. Lipoxin A4 (LXA4) and
aspirin-triggered 15-epi-LXA4 predominantly through FPR2/ALX
attenuate MPO-stimulated degranulation, upregulation of surface
expression of Mac-1, and superoxide formation, thus effectively
interrupting this loop. LXA4 and15-epi-LXA4 redirect neutrophils to
apoptosis by overriding the powerful survival signals from MPO
through inducing loss of expression of Mcl-1 and aggravating
mitochondrial dysfunction. Lipoxins also enhance phagocytosis of
apoptotic neutrophils by macrophages.
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RESOLVIN E1 PROMOTES PHAGOCYTOSIS-INDUCED NEUTROPHIL
APOPTOSIS
Resolvin E1 is synthesized from the ω-3 polyunsaturated fatty
acid eicosapentaenoic acid during the resolution phase of acute
inflammation with leukocyte 5-lipoxygenase playing a pivotal
temporal role in the biosynthesis pathway (Serhan et al., 2000;
Oh et al., 2011). RvE1 binds to the ChemR23 and (as a par-
tial agonists/antagonist) the leukotriene B4 (LTB4) receptor BLT1
(Arita et al., 2005; Oh et al., 2011) and exhibits potent anti-
inflammatory and pro-resolution activities. Thus, RvE1 inhibits
neutrophil recruitment, facilitates efferocytosis (Serhan et al.,
2002, 2008; Ohira et al., 2010; Oh et al., 2011; Serhan and Petasis,
2011), promotes mucosal surface clearance (Campbell et al., 2007),
and induces generation of LXA4 (Haworth et al., 2008).These
potent pro-resolution actions were also demonstrated in vari-
ous experimental models, including peritonitis (Oh et al., 2011),
polymicrobial sepsis (Schwab et al., 2007), and bacterial pneu-
monia (Seki et al., 2010) Moreover, studies on ChemR23-null
mice demonstrated an endogenous anti-inflammatory role for
ChemR23 (Cash et al., 2008).
Recent results indicate that RvE1 can modulate neutrophil
apoptosis (El Kebir et al., 2012). While at low nanomolar con-
centrations, RvE1 per se does not affect the constitutive death
program in neutrophils, it enhances Mac-1-mediated phagocy-
tosis of complement-opsonized bacteria and yeast, leading to
increased ROS generation by NADPH oxidase and subsequent
activation of caspase-8 and caspase-3 (El Kebir et al., 2012). RvE1
also attenuates ERK and Akt-mediated survival cues generated
by MPO and decreases Mcl-1 expression, thereby reinforcing the
shift toward apoptosis (El Kebir et al., 2012). These actions of
RvE1 are predominantly mediated via BLT1 in vitro, indicat-
ing that resolution mechanisms may also be activated via this
type of LTB4 receptor. In contrast, RvE1 stimulation of phago-
cytosis of live E. coli and apoptotic neutrophils by macrophages
leads to a macrophage phenotype switch without evoking apop-
tosis (Arita et al., 2005; Schwab et al., 2007; Oh et al., 2011).
Since in macrophages RvE1 signals via ChemR23 (Ohira et al.,
2010), RvE1 may exert different pro-resolution actions via dis-
tinct receptors, and concurrent activation of these circuits may
be critical for optimal resolution. The neutrophil apoptosis-
promoting action of RvE1 was also evident in experimental models
of acute respiratory distress (ARDS) and pneumonia (El Kebir
et al., 2012), in which MPO has been implicated in mediating
lung injury. RvE1 administered at the peak of inflammation, pro-
moted apoptosis in neutrophils in situ, enhanced recruitment of
monocytes to the airways, and facilitated clearance of apoptotic
neutrophils and other cells and tissue repair (El Kebir et al., 2012),
consistent with the original properties defining RvE1 actions
(Serhan et al., 2008). Efficient resolution of acute lung inflam-
mation is intimately linked to apoptosis of neutrophils within
the airways, as the pan-caspase inhibitor zVAD-fmk prevented
RvE1-induced dramatic reduction in the number of infiltrating
neutrophils (El Kebir et al., 2012) and aggravated lung injury
likely due to persisting presence of neutrophils. Eicosapentaenoic
acid is also a substrate for acetylated COX-2, which generates
aspirin-triggered resolvins that shares anti-inflammatory actions
of native resolvins (Spite and Serhan, 2010). These would raise
the possibility that resolvin-triggered phagocytosis-induced neu-
trophil apoptosis could contribute to the beneficial actions of
aspirin.
OTHER APPROACHES TO INDUCE NEUTROPHIL APOPTOSIS IN VIVO
Given the complexity of pathways involved in the regulation of
neutrophil apoptosis, a number of agents have been identified
that could shift the balance of survival and pro-apoptosis cues
toward apoptosis. More importantly, some of these agents have
been found to possess pro-resolution properties in diverse models
of inflammation (see also Figure 4).
At the light of its pre-eminence as a key survival protein, Mcl-
1 is an attractive target for therapeutic induction of apoptosis.
The cyclin-dependent kinase inhibitor R-roscovitine (Seliciclib
or CYC202) accelerates degradation of Mcl-1 and inhibits tran-
scriptional activity in neutrophils by preventing cyclin-dependent
kinase (CDK) 7 and 9-mediated phosphorylation of RNA poly-
merase II (Leitch et al., 2012), thereby inducing apoptosis in
inflammatory cells in vitro (Rossi et al., 2006; Leitch et al., 2012).
Consistently, treatment of with R-roscovitine enhances resolu-
tion of pleuritis and bleomycin-induced lung injury (Rossi et al.,
2006) and pneumococcal meningitis in mice (Koedel et al., 2009),
coinciding with increased numbers of apoptotic neutrophils in
the airways and cerebrospinal fluid, respectively. R-roscovitine
induces apoptosis in neutrophils from patients with cystic fibro-
sis, whereas the selective CFTR inhibitor CFTRInh172 does not
affect constitutive apoptosis in neutrophils from healthy volun-
teers (Moriceau et al., 2010). Suppressed neutrophil apoptosis in
cystic fibrosis is likely not simply a consequence of chronic infec-
tion. Since cystic fibrosis is associated with enhanced formation of
MPO-generated oxidants, it would be interesting to know whether
MPO is one of the yet unidentified modulatory factors intrinsic
to CF.
The pro-resolution mediator annexin A1 binds to FPR2/ALX,
which is also a receptor for LXA4 and 15-epi-LXA4, and accelerates
neutrophil apoptosis in various murine models of inflamma-
tion by decreasing survival signals and Mcl-1 expression (Solito
et al., 2003; Perretti and D’Acquisto, 2009; Perretti, 2012). A
recent study reported that annexin A1 in inflammatory exudates
promotes active resolution and augments neutrophil apoptosis
in LPS-induced pleurisy in mice (Vago et al., 2012). Intrigu-
ingly, annexin A1-deficient mice exhibit an exaggerated inflam-
matory response and reduced Mac-1 expression on neutrophils
(Hannon et al., 2003). Whether the pro-resolution actions of
annexin A1 also involve modulation of signaling through Mac-1
remain to be explored. The phosphodiesterase 4 inhibitor rolipram
has also recently been found to promote neutrophil apoptosis
and resolution of LPS-induced pleurisy in mice by decreasing
PI3K/Akt survival signaling and Mcl-1 expression (Sousa et al.,
2010).
Another possibility is induction of caspase activity, the major
effectors of apoptosis. Although selective caspase activators are
currently not available, recent studies demonstrated the pro-
resolving action of the death receptor ligand TRAIL, which
may function as a physiological brake to limit the inflammatory
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FIGURE 4 |Therapeutic induction of neutrophil apoptosis with
demonstrated pro-resolution actions in vivo. Treatment of experimental
animals with CDK inhibitor drugs (e.g., R-roscovitine), 15-epi-LXA4, RvE1,
rTRAIL, or annexin A1 enhance the resolution of inflammation by
promoting apoptosis of neutrophils that have emigrated into tissues in
various models of inflammation. Roscovitine through yet unidentified
mechanisms, 15-epi-LXA4 through attenuating MPO-triggered
Mac-1-mediated survival signaling and annexin A1 through dampening
intracellular survival signaling down-regulate expression of the key survival
protein Mcl-1. RvE1 enhances phagocytosis-induced apoptosis, leading to
activation of caspase-8 and suppression of Mcl-1.rTRAIL activates
caspase-8.
response (Leitch et al., 2011). Thus, TRAIL-deficiency in mice
is associated with delayed neutrophil apoptosis and exaggerated
inflammatory response (Falschlehner et al., 2009; McGrath et al.,
2011). Conversely, rTRAIL was found to facilitate neutrophil apop-
tosis through inducing activation of caspase-8 both in vitro and
in vivo (Renshaw et al., 2003; McGrath et al., 2011). Consistent with
enhanced neutrophil apoptosis, treatment with rTRAIL acceler-
ated resolution of LPS-induced lung injury and zymosan-induced
peritonitis in TRAIL-deficient mice (McGrath et al., 2011). Up-
regulation of TRAIL has also been implicated in mediating TLR4
signaling through IFN-β to promote neutrophil apoptosis and lim-
iting lung inflammation in a mouse model of ARDS (Leu et al.,
2011).
Targeting pro-survival pathways to promote resolution has
also been investigated at the level of MAPK and NF-κB signal-
ing. As discussed above, pharmacological blockade of ERK 1/2
and/or PI3K prevents GM-CSF or MPO-induced neutrophil sur-
vival in vitro. The efficacy of the MEK/ERK inhibitor PD98059
in the resolution of inflammation was also demonstrated in the
carrageenan-induced pleurisy model in rats (Sawatzky et al., 2006).
NF-κB blockers have potential anti-inflammatory actions (Gosh
and Hayden, 2008) and may also affect resolution. An oligonu-
cleotide decoy to NF-κB was found to enhance neutrophil apop-
tosis and phagocytosis by macrophages in a rat model of chronic
inflammation (Maiuri et al., 2004). Increased apoptosis correlated
with increases in p53 or Bax expression and decreases in Bcl-2
protein expression. Systemic injection of a cell-permeable form of
IκBα (Tat-srIκBα chimera) reduced leukocyte trafficking into the
pleural cavity and increased caspase-3 activity and apoptosis in
emigrated cells (Blackwell et al., 2004). In contrast, the Tat-srIκBα
chimera produced only marginal reductions in neutrophil migra-
tion and apoptosis if administered locally (Blackwell et al., 2004),
indicating that the route and timing of administration may be
critical for exerting beneficial actions. In another study, selective
NF-κB inhibitors failed to affect neutrophil accumulation in the
pleural cavity (Sousa et al., 2010).
CONCLUSION
Intensive research during the past decade has revealed that inflam-
mation does not terminate spontaneously; rather resolution is a
tightly controlled active process. During the past decade, a num-
ber of novel mediators, including lipids, peptides, and proteins,
and signaling circuits have been identified. Timely and efficient
removal of migrated neutrophils requires these cells to undergo
apoptosis. A growing body of evidence supports an important
role for neutrophil apoptosis as a critical control point for the out-
come of inflammation. Neutrophil surface receptors, including the
adhesion molecule Mac-1 integrates opposing cues that modulate
life and death decisions and therefore the outcome of inflam-
mation. Outside-in signaling through Mac-1 is also a target for
endogenous molecules, such as lipoxins, resolvin E1, and synthetic
compounds to counter pro-survival and/or induce pro-apoptosis
signals. Interfering with Mac-1 function may have two important
benefits: inhibition of neutrophil trafficking into the inflamed site
and acceleration of neutrophil clearance from inflamed tissues
through the process of efferocytosis. Indeed, results from experi-
mental models demonstrate that redirecting neutrophils to apop-
tosis and facilitating their clearance by macrophages are essential
for enhancing resolution of acute inflammation. While clinical tri-
als with these compounds remain distant, therapeutic induction
of neutrophil apoptosis at the inflammatory site hold promise as
a powerful pro-resolving intervention and may fulfill urgent, yet
unmet clinical needs to prevent the deleterious consequences of
inflammation.
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